Overview
Tay-Sachs disease, juvenile form (also called juvenile GM2 gangliosidosis or subacute Tay-Sachs disease) is a rare inherited condition that affects the nervous system. It is caused by a shortage of an enzyme called hexosaminidase A (Hex A), which is needed to break down a fatty substance called GM2 ganglioside in the brain. Without enough of this enzyme, GM2 ganglioside builds up in nerve cells, gradually damaging them and causing progressive neurological problems. Unlike the more well-known infantile form of Tay-Sachs, the juvenile form typically begins between ages 2 and 10. Children who were previously developing normally may start to lose skills they had already learned. Early signs often include clumsiness, difficulty with coordination, speech problems, and trouble with learning. Over time, the disease leads to worsening muscle weakness, difficulty walking, seizures, vision loss, and progressive intellectual decline. Eventually, affected children lose the ability to move, communicate, and swallow independently. There is currently no cure for juvenile Tay-Sachs disease. Treatment focuses on managing symptoms and maintaining quality of life for as long as possible. This includes medications for seizures, physical therapy, speech therapy, and nutritional support. Research into potential therapies such as gene therapy, enzyme replacement therapy, and substrate reduction therapy is ongoing, offering hope for future treatments. The disease is progressive, and families benefit greatly from a supportive, multidisciplinary care team.
Also known as:
Key symptoms:
Loss of previously learned skills (developmental regression)Difficulty with coordination and balance (ataxia)Slurred or worsening speechMuscle weaknessDifficulty walkingSeizuresVision lossIntellectual declineDifficulty swallowingBehavioral changesInvoluntary muscle movements or spasticityLoss of ability to communicateProgressive loss of independence
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Juvenile
Begins in the teen years
Treatments
No FDA-approved treatments are currently listed for Tay-Sachs disease, juvenile form.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Tay-Sachs disease, juvenile form at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Tay-Sachs disease, juvenile form.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Tay-Sachs disease, juvenile form.
Community
No community posts yet. Be the first to share your experience with Tay-Sachs disease, juvenile form.
Start the conversation →Latest news about Tay-Sachs disease, juvenile form
No recent news articles for Tay-Sachs disease, juvenile form.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the expected rate of progression for my child's specific form of juvenile Tay-Sachs?,What medications and therapies are recommended right now, and what side effects should I watch for?,Are there any clinical trials or experimental treatments my child might be eligible for?,When should we consider a feeding tube or other supportive interventions?,Should other family members or future pregnancies be tested for carrier status?,What palliative care and support services are available to our family?,How can we best support my child's quality of life and comfort as the disease progresses?
Common questions about Tay-Sachs disease, juvenile form
What is Tay-Sachs disease, juvenile form?
Tay-Sachs disease, juvenile form (also called juvenile GM2 gangliosidosis or subacute Tay-Sachs disease) is a rare inherited condition that affects the nervous system. It is caused by a shortage of an enzyme called hexosaminidase A (Hex A), which is needed to break down a fatty substance called GM2 ganglioside in the brain. Without enough of this enzyme, GM2 ganglioside builds up in nerve cells, gradually damaging them and causing progressive neurological problems. Unlike the more well-known infantile form of Tay-Sachs, the juvenile form typically begins between ages 2 and 10. Children who we
How is Tay-Sachs disease, juvenile form inherited?
Tay-Sachs disease, juvenile form follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Tay-Sachs disease, juvenile form typically begin?
Typical onset of Tay-Sachs disease, juvenile form is juvenile. Age of onset can vary across affected individuals.